UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 293

Sortiert nach

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Current medical research and opinion, 2013-04, Vol.29 (4), p.305-313

2013

Volltextzugriff (PDF)

The position of strontium ranelate in today’s management of osteoporosis

Osteoporosis international, 2015-06, Vol.26 (6), p.1667-1671

2015

Volltextzugriff (PDF)

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.592-601

2013

Volltextzugriff (PDF)

Treatment of osteoporosis in men

Bone (New York, N.Y.), 2013-03, Vol.53 (1), p.134-144

2013

Volltextzugriff (PDF)

A reappraisal of generic bisphosphonates in osteoporosis

Osteoporosis international, 2012-01, Vol.23 (1), p.213-221

2012

Volltextzugriff (PDF)

Osteoporose: Pathogenese, Diagnostik und Therapiemöglichkeiten

1, 2019

Volltextzugriff (PDF)

Osteoporose: Pathogenese, Diagnostik und Therapiemöglichkeiten

J. D. Ringe / J. D. Ringe

2019

Volltextzugriff (PDF)

Efficacy of risedronate in men with primary and secondary osteoporosis : results of a 1-year study

Rheumatology international, 2006-03, Vol.26 (5), p.427-431

2006

Volltextzugriff (PDF)

Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile

Rheumatology international, 2014-05, Vol.34 (5), p.727-732

2014

Volltextzugriff (PDF)

Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate

Osteoporosis international, 2005-12, Vol.16 (12), p.2063-2068

2005

Volltextzugriff (PDF)

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

Osteoporosis international, 2003-10, Vol.14 (10), p.801-807

2003

Volltextzugriff (PDF)

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

Osteoporosis international, 2013-12, Vol.24 (12), p.2971-2981

2013

Volltextzugriff (PDF)

Strontium ranelate: an effective solution for diverse fracture risks

Osteoporosis international, 2010-06, Vol.21 (Suppl 2), p.431-436

Ringe, J. D.

2010

Volltextzugriff (PDF)

Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study

The journal of clinical endocrinology and metabolism, 2001-11, Vol.86 (11), p.5252-5255

2001

Volltextzugriff (PDF)

Longitudinal change in clinical fracture incidence after initiation of bisphosphonates

Osteoporosis international, 2010-06, Vol.21 (6), p.1021-1029

2010

Volltextzugriff (PDF)

Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study

Rheumatology international, 2004-03, Vol.24 (2), p.110-113

2004

Volltextzugriff (PDF)

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)

Rheumatology international, 2007-03, Vol.27 (5), p.425-434

2007

Volltextzugriff (PDF)

A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover

Clinical and experimental rheumatology, 2007-09, Vol.25 (5), p.766

2007

Volltextzugriff (PDF)

Three‐monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid‐induced osteoporosis

Rheumatology (Oxford, England), 2003-06, Vol.42 (6), p.743-749

2003

Volltextzugriff (PDF)

Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol

Rheumatology international, 2007-12, Vol.28 (2), p.103-111

2007

Volltextzugriff (PDF)

Management of osteoporosis of the oldest old

Osteoporosis international, 2014-11, Vol.25 (11), p.2507-2529

2014

Volltextzugriff (PDF)

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

Rheumatology international, 2004-03, Vol.24 (2), p.63-70

2004

Volltextzugriff (PDF)

Erratum to: Management of osteoporosis of the oldest old

Osteoporosis international, 2014-11, Vol.25 (11), p.2531-2531

2014

Volltextzugriff (PDF)

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis

Osteoporosis international, 2009-11, Vol.20 (11), p.1895-1902

2009

Volltextzugriff (PDF)

Treatment of male osteoporosis: Recent advances with alendronate

Osteoporosis international, 2002-03, Vol.13 (3), p.195-199

2002

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(212)

Publikationsform

Artikel
(241)
Buchkapitel
(43)
Bücher
(5)
Webseiten
(3)
Texte
(1)

Sprache

Deutsch
(179)
Englisch
(146)
Japanisch
(13)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(175)
Female
(106)
Life Sciences & Biomedicine
(98)
Science & Technology
(98)
Aged
(84)
Male
(84)
Middle Aged
(83)
Osteoporosis - Drug Therapy
(60)
Adult
(42)
Osteoporosis
(42)
Biological And Medical Sciences
(40)
Bone Density - Drug Effects
(38)
Medical Sciences
(38)
General & Internal Medicine
(35)
Rheumatology
(32)
Endocrinology & Metabolism
(31)
Risk Factors
(27)
Bone Density Conservation Agents - Therapeutic Use
(24)
Pharmacology. Drug Treatments
(23)
Bone Density
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

The position of strontium ranelate in today’s management of osteoporosis

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men

Treatment of osteoporosis in men

A reappraisal of generic bisphosphonates in osteoporosis

Osteoporose: Pathogenese, Diagnostik und Therapiemöglichkeiten

Osteoporose: Pathogenese, Diagnostik und Therapiemöglichkeiten

Efficacy of risedronate in men with primary and secondary osteoporosis : results of a 1-year study

Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile

Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

Strontium ranelate: an effective solution for diverse fracture risks

Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study

Longitudinal change in clinical fracture incidence after initiation of bisphosphonates

Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study

Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)

A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover

Three‐monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid‐induced osteoporosis

Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol

Management of osteoporosis of the oldest old

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

Erratum to: Management of osteoporosis of the oldest old

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis

Treatment of male osteoporosis: Recent advances with alendronate

Suchergebnisse filtern